Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined intravenous and intraarterial neoadjuvant chemotherapy for advanced gastric cancer
ChiCTR-TRC-12002046Phase 2Completed
- Sponsor
- Research Institute of General Surgery, Jinling Hospital
- Start
- Jul 2006
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of fluorouracil, folinic acid, oxaliplatin, epirubicin and etoposide in gastric cancer (GC) (2 arms), sponsored by Research Institute of General Surgery, Jinling Hospital. Primary endpoints: overall survival and time to progression. Started Jul 2006; status: completed.
02
Drugs
fluorouracilfolinic acidoxaliplatinepirubicinetoposide
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR-TRC-12002046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002046.